DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Hsu YC, Nguyen MH, Mo LR. , et al.
Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk.
Aliment Pharmacol Ther 2019;
49 (01) 107-115
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.